Spyre Therapeutics Announces Grants of Inducement Awards Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the Company or Spyre ), a development-stage biotechnology company advancing best-in-class antibody...
Monday, June 3, 2024 BiopharmaWatch Research 1 min read
Key Takeaway: Spyre Therapeutics, Inc. announced the grant of inducement awards in the form of stock options to its employees. These options come with a 10-year term and an exercise price set at $36.79, reflecting the stock's closing price as of June 3, 2024. The vesting schedule includes a significant time frame that connects employees' rewards to their continued service with the company. This strategic move is seen as a commitment to fostering talent within the organization.
Price reaction · baseline $34.95 (2024-05-31 close) · clean, no other SYRE news in the window
day 0 close · peak
+5.3%
day 1
-2.4%
day 3
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Spyre Therapeutics has issued stock options as inducement awards, indicating growth and investment in talent.
The options have a long vesting period, aligning employee interests with company success over time.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+249%
120-day peak, hindsight
Typical move
3.2%
average across 3 past catalysts
Cash runway
~49 mo
Minimal dilution risk
Lead asset
Co-ArgI-PEG modified human arginase I
Phase 2 · Acute Myeloid Leukemia
Full Press Release Details
The stock options were granted with a 10-year term and an exercise price equal to $36.79 , the closing price per share of Spyre's common stock as reported by Nasdaq on June 3, 2024 . The options granted to each employee shall vest and become exercisable as to one-fourth (1/4th) of the shares subject to the respective options on the first anniversary of the employee's start date, and one-forty-eighth (1/48th) of the shares subject to the respective options shall vest and become exercisable monthly thereafter, in each case, subject to continuous service with Spyre through the applicable vesting dates. The stock options are subject to the terms of the 2018 Plan.
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
Frequently Asked Questions
What is the exercise price of Spyre's stock options?
The exercise price is $36.79 per share.
When do Spyre's stock options start to vest?
The options start to vest on the first anniversary of the employee's start date.
How will shares vest after the first anniversary?
After the first anniversary, shares will vest monthly at a rate of 1/48th.
What is the term of the stock options granted by Spyre?
The stock options have a term of 10 years.
What conditions apply to vesting of Spyre's stock options?
Vesting is subject to continuous service with Spyre through the vesting dates.